A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
نویسندگان
چکیده
BACKGROUND The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice. METHODS Sixteen participating centers from the PEPs project recruited 335 first episode of psychosis patients, aged 7 to 35 years. This article describes and discusses the psychopharmacological interventions and safety profiles at baseline and during a 60-day pharmacovigilance period. RESULTS The majority of first episode of psychosis patients received a second-generation antipsychotic (96.3%), orally (95%), and in adjusted doses according to the product specifications (87.2%). A total of 24% were receiving an antipsychotic polytherapy pattern at baseline, frequently associated with lower or higher doses of antipsychotics than the recommended ones. Eight patients were taking clozapine, all in monotherapy. Males received higher doses of antipsychotic (P=.043). A total of 5.2% of the patients were being treated with long-acting injectable antipsychotics; 12.2% of the patients received anticholinergic drugs, 12.2% antidepressants, and 13.7% mood stabilizers, while almost 40% received benzodiazepines; and 35.52% reported at least one adverse drug reaction during the pharmacovigilance period, more frequently associated with higher antipsychotic doses and antipsychotic polytherapy (85.2% vs 45.5%, P<.001). CONCLUSIONS These data indicate that the overall pharmacologic prescription for treating a first episode of psychosis in Spain follows the clinical practice guideline recommendations, and, together with security issues, support future research of determinate pharmacological strategies for the treatment of early phases of psychosis, such as the role of clozapine, long-acting injectable antipsychotics, antipsychotic combination, and the use of benzodiazepines.
منابع مشابه
تأخیر در درمان و مسیر مراجعه بیماران دچار پسیکوز بار اول
AbstractObjectives: The aim of this study was investigation the duration of untreated psychosis (DUP), associated factors and pathways to care among patients with first episode psychosis admitted to Roozbeh Hospital. Method: In this cross-sectional study, 91 patients with the diagnosis of first episode psychosis admitted to Roozbeh Hospital in Tehran, were assessed regarding the duration of unt...
متن کاملبررسی ویژگیهای دموگرافیک، بیماری و درمان در بیماران
Background and Aim: In recent years, a number of studies have been done on patients with first-episode of psychosis. The importance of this issue is to improve outcome of the psychosis. Due to lack of similar research in Iran and differences in culture as well as in treatment program, investigation of demographic characteristics and treatment of patients with first-episode of psychosis could be...
متن کاملنرمنشانههای عصبی در بیماران دچار نخستین دوره سایکوز، بستگان درجه اول آنها و افراد سالم
Abstract Objectives: This study aimed to evaluate and compare neurological soft signs (NSS) in patients with first episode psychosis, in their first-degree relatives, and in healthy control subjects. Method: Thirty patients with first-episode psychosis, 30 of their first-degree relatives, and 30 healthy controls were evaluated by the Structured Clinical Interview for DSM-IV (SCID) for p...
متن کاملAwareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital
Background and Objectives: Pharmacovigilance is central to the control of the menace of adverse drugs reactions. Despite the fact that development of policy and practice framework to improve patients’ safety partly rely on availability of authentic data on pharmacovigilance activities, knowledge about pharmacovigilance activities among healthcare professionals in Nigeria is limited. To help fil...
متن کاملPremorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
BACKGROUND The extent to which socio-demographic, clinical, and premorbid adjustment variables contribute to cognitive deficits in first-episode schizophrenia spectrum disorders remains to be ascertained. AIMS To examine the pattern and magnitude of cognitive impairment in first-episode psychosis patients, the profile of impairment across psychosis subtypes and the associations with premorbid...
متن کامل